Showing posts with label Product liability. Show all posts
Showing posts with label Product liability. Show all posts

Tuesday, March 19, 2019

Air & Liquid Systems Corp. v. DeVries, Docket 17-1104


Tort Law
Maritime Tort Case
Maritime Law
Navy Veterans
Common-Law Court
Asbestos
Product Manufacturer
Duty to Warn
Liability for Harms Caused by Later-Added Third-Party Parts



Summary: In the maritime tort context, a product manufacturer has a duty to warn when its product requires incorporation of a part, the manu­facturer knows or has reason to know that the integrated product is likely to be dangerous for its intended uses, and the manufacturer has no reason to believe that the product’s users will realize that danger.

In maritime tort cases, we act as a common-law court, subject to any controlling statutes enacted by Congress. See Exxon Shipping Co. v. Baker, 554 U. S. 471, 507–508 (2008).

Three approaches have emerged on how to apply that “duty to warn” principle when a manufacturer’s product requires later incorporation of a dangerous part in order for the integrated product to function as intended. The first—the foreseeability rule—provides that a manu­facturer may be liable when it was foreseeable that its product would be used with another product or part, even if the manufacturer’s product did not require use or incorporation of that other product or part. The second—the bare-metal defense—provides that if a manu­facturer did not itself make, sell, or distribute the part or incorporate the part into the product, the manufacturer is not liable for harm caused by the integrated product—even if the product required incor­poration of the part and the manufacturer knew that the integrated product was likely to be dangerous for its intended uses. A third ap­proach, falling between those two, imposes on the manufacturer a duty to warn when its product requires incorporation of a part and the manufacturer knows or has reason to know that the integrated prod­uct is likely to be dangerous for its intended uses.

The third approach is most appropriate for this maritime context.

Requiring the product manufacturer to warn when its product requires incorpora­tion of a part that makes the integrated product dangerous for its in­tended uses is especially appropriate in the context of maritime law, which has always recognized a “special solicitude for the welfare” of sailors. American Export Lines, Inc. v. Alvez, 446 U. S. 274, 285.

The maritime tort rule adopted here encompasses all of the fol­lowing circumstances, so long as the manufacturer knows or has rea­son to know that the integrated product is likely to be dangerous for its intended uses, and the manufacturer has no reason to believe that the product’s users will realize that danger: (i) a manufacturer di­rects that the part be incorporated; (ii) a manufacturer itself makes the product with a part that the manufacturer knows will require re­placement with a similar part; or (iii) a product would be useless without the part.



(U.S. Supreme Court, March 19, 2019, Air & Liquid Systems Corp. v. DeVries, Docket 17-1104, J. Kavanaugh)

Thursday, December 21, 2017

T.H. v. Novartis Pharmaceuticals Corporation, S233898


Product liability: Tort: Warning: Product warning: Failure to warn:



(Cf. Groll v. Shell Oil Co. (1983) 148 Cal.App.3d 444, 449 [manufacturer of bulk fuel owed no duty to the ultimate consumer where the manufacturer provided adequate warnings to the distributor, “who subsequently packages, labels and markets the product,” and the manufacturer thus “did not have the ability to prepare the warning”].)



(Cal. S.C., Dec. 21, 2017, T.H. v. Novartis Pharmaceuticals Corporation, S233898).



Le producteur d'un carburant vendu en gros n'est redevable d'aucun devoir d'aviser des risques envers le consommateur final, lorsque le producteur a donné un avis adéquat au distributeur, auquel revient les tâches de conditionner et d'écouler le produit.

Monday, August 29, 2016

Bristol-Myers Squibb Co. v. Super. Ct., S221038


Causes of action (Cal.): Product liability: Unfair competition: Loss of consortium:

(…) Eight separate amended complaints were filed in San Francisco Superior Court by or on behalf of 678 individuals, consisting of 86 California residents and 592 nonresidents, all of whom allegedly were prescribed and ingested Plavix, a drug created and marketed by BMS, and as a result suffered adverse consequences.

13 causes of action: Each amended complaint contains the same 13 causes of action: strict products liability (based on both design defect and manufacturing defect); negligence; breach of implied warranty; breach of express warranty; deceit by concealment (Civ. Code, §§ 1709, 1710); negligent misrepresentation; fraud by concealment; unfair competition (Bus. & Prof. Code, § 17200); false or misleading advertising (Bus. & Prof. Code, § 17500); injunctive relief for false or misleading advertising (Civ. Code, § 1750 et. seq.); wrongful death; and loss of consortium.


(Cal. S.C., August 29, 2016, Bristol-Myers Squibb Co. v. Super. Ct.,  S221038, Cantil-Sakauye, C.J., Liu, Cuéllar, Kruger, JJ., concur., Werdegar, Chin, Corrigan, JJ., diss.).


Un exemple des théories juridiques de responsabilité qui peuvent être invoquées dans une affaire qui combine responsabilité délictuelle et responsabilité du fait des produits : 13 théories les plus courantes dans ce type d’affaires, certaines émanant du droit des contrats.